Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

May 1, 2022

Study Completion Date

July 30, 2022

Conditions

Acute Ischemic Stroke

Interventions

DRUG

AngongNiuhuang pill

This group will receive AngongNiuhuang pill 1pill qd/day for 5-day.

DRUG

Placebo of AngongNiuhuang pill

This group will receive placebo of AngongNiuhuang pill 1pill qd/day for 5-day.

OTHER

Standard treatment

The other treatments according to guidelines for standard treatment of acute ischemic stroke

Trial Locations (1)

Department of Neurology,Peking Union Medical College Hospital,Shuaifuyuan 1,Dong Cheng District. Beijing, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER

NCT04475328 - Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL) | Biotech Hunter | Biotech Hunter